# Rituximab in the treatment of anti-HMGCR immune-mediated necrotizing myopathy: Two cases successfully treated

**Authors:** Giulia Micheli, Lorenzo Salvati, Boaz Palterer, Emanuele Vivarelli, Alessio Mazzoni, Nila Volpi, Alessandra Vultaggio, Andrea Matucci, Lorenzo Cosmi, Daniele Cammelli, Paola Parronchi

PMC · DOI: 10.1515/rir-2025-0014 · Rheumatology and Immunology Research · 2025-07-01

## Full-text entities

- **Genes:** HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) [NCBI Gene 3156] {aka LDLCQ3, LGMDR28, MYPLG}
- **Diseases:** myopathy (MESH:D009135)
- **Chemicals:** Rituximab (MESH:D000069283)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12212632/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12212632/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12212632/full.md

---
Source: https://tomesphere.com/paper/PMC12212632